Wednesday, August 20, 2008
Search
Privacy Statement
|
Terms of Use
|
Legal Statement
Home
Login
Contact
Register
Login
Public Pages
»
ENERCA services
»
Anaemias covered
»
Haemoglobin H
Professionals
ENERCA Experts
Diagnosis Flowchart
On-line Forum
Database/Registry
Guidelines/Recommendations
Education and Training
Quality Assurance
MAC
Public
About ENERCA
About Anaemia
ENERCA Services
Rare Anaemias
Expert Centres
Patient Associations
On-line Forum
Useful Links
Events
NewsLetter
Last update: 10 - 03 - 2008
Haemoglobin H
Alpha
thalassaemia
Alpha thalassaemia
is the consequence of an inherited defective synthesis of alpha globin, one of both specific protein chains of the haemoglobin molecule. It is controlled by four genes This disorder is mainly caused by deletions of the alpha genes, and shows variable clinical presentation according to the number of affected genes: alpha thalassaemia trait or alpha + (deletion of 1 or 2 genes) with microcytosis, normal HbA2 and HbF; there is no clinical manifestations, b) Hb H disease (deletion of 3 genes) is characterized by severe chronic haemolytic anaemia and c) Hydrops fetalis (deletion of 4 genes) which causes in utero death between the 5th month of pregnancy and birth.
Acquired alpha-thalassaemia is the best characterized of the acquired red blood cell disorders in patients with haematologic malignancy, and it is almost always associated with a myelodysplastic syndrome (MDS).
Synonym:
Haemoglobin H
Copyright 2006 by ENERCA
DotNetNuke® is copyright 2002-2008 by DotNetNuke Corporation